4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-037724
Chief Medical Officer sold 2,000 shares at an average $92.89 ($185,786)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-12 | Exercise or conversion : show line 1 in the form | +2,000 | $35.16 | $70,320 | 2,881 | D |
| 2018-06-12 | Sale : show line 2 in the form | −1,800 | $92.84 | $167,112 | 1,081 | D |
| 2018-06-12 | Sale : show line 3 in the form | −200 | $93.37 | $18,674 | 881 | D |
| Open-market sales · 2,000 sh · avg $92.89 · $185,786 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-12 | Exercise or conversion : show line 4 in the form Stock option (right to buy) | −2,000 | 95,000 | D |
Loading xslF345X03/doc4.xml…